Price Alert

Collegium Pharmaceutical ... (COLL)

NASDAQ: COLL · Real-Time Price · USD

37.71

0.55 (1.48%)

At close: Aug 15, 2025, 3:59 PM

37.74

0.08%

After-hours: Aug 15, 2025, 04:34 PM EDT

Collegium Pharmaceutical Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	177.76M	181.95M	159.3M	145.28M	144.92M	149.75M	136.71M	135.55M	144.77M	129.62M	127.01M	123.55M	83.75M	27.36M	78.84M	82.94M	87.72M
Cost of Revenue	80.43M	83.66M	62.51M	54.47M	53.47M	55.12M	56.4M	61.72M	67.36M	79.83M	68.17M	71.19M	35.26M	28.7M	32.73M	32.7M	32.12M
Gross Profit	97.32M	98.29M	96.79M	90.81M	91.46M	94.63M	80.31M	73.83M	77.4M	49.79M	58.84M	52.36M	48.5M	-1.33M	46.11M	50.24M	55.6M
Operating Income	21.69M	38.11M	34.84M	47.47M	49.47M	61.69M	45.01M	35.63M	24.63M	-30.32M	20.47M	11.11M	-10.01M	-34.12M	14.15M	16.41M	21.19M
Interest Income	2.23M	1.81M	3.28M	4.4M	4.49M	4.3M	4.54M	4.03M	2.75M	1.03M	11K	5K	4K	3K	3K	3K	3K
Pretax Income	3.12M	17.27M	15.58M	29.1M	36.62M	46.71M	28.78M	17.8M	-17.56M	-7.79M	1.43M	-6.65M	-15.84M	-38.88M	9.04M	10.99M	15.47M
Net Income	2.42M	12.54M	9.34M	19.61M	27.71M	31.94M	20.63M	13.01M	-17.43M	-7.2M	457K	-5.19M	-13.07M	-25.03M	8.05M	72.84M	15.66M
Selling & General & Admin	76.42M	63.09M	61.95M	43.34M	41.98M	32.94M	35.3M	38.19M	52.77M	38.03M	38.37M	41.25M	54.53M	26.6M	30.51M	30.37M	31.48M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.98M	n/a	n/a	3.98M	1.61M	1.45M	3.46M	2.93M
Other Expenses	-786K	-2.91M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.98M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	75.64M	60.18M	61.95M	43.34M	41.98M	32.94M	35.3M	38.19M	52.77M	38.03M	38.37M	41.25M	58.51M	28.21M	31.96M	33.83M	34.41M
Interest Expense	20.79M	22.65M	18.39M	15.59M	17.34M	19.28M	20.77M	21.86M	21.43M	20.57M	19.05M	17.76M	5.83M	4.76M	5.12M	5.42M	5.72M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	7.41M	n/a	n/a	n/a	11.74M	n/a	n/a	n/a	4.19M	n/a	n/a	n/a
Cost & Expenses	156.07M	146.75M	124.46M	97.81M	95.45M	88.06M	91.7M	99.91M	120.14M	117.86M	106.55M	112.44M	93.77M	56.91M	64.69M	66.53M	66.53M
Income Tax Expense	705K	4.73M	6.25M	9.49M	8.91M	14.77M	8.15M	4.79M	-131K	-592K	975K	-1.46M	-2.77M	-13.84M	991K	-61.85M	-188K
Shares Outstanding (Basic)	31.79M	32.08M	32.26M	32.43M	32.33M	32.3M	33.74M	34.62M	34.32M	33.58M	34.06M	34M	33.51M	34.11M	35.37M	35.3M	34.95M
Shares Outstanding (Diluted)	32.84M	40.11M	40.16M	40.38M	41.44M	41.28M	42.06M	42.85M	34.32M	33.58M	34.57M	34M	33.67M	34.12M	36.26M	41.29M	41.16M
EPS (Basic)	0.08	0.39	0.33	0.60	0.86	0.99	0.61	0.38	-0.51	-0.21	0.01	-0.15	-0.39	-0.73	0.23	2.06	0.45
EPS (Diluted)	0.07	0.36	0.27	0.52	0.71	0.82	0.53	0.34	-0.51	-0.21	0.01	-0.15	-0.39	-0.73	0.22	1.79	0.41
EBITDA	80.48M	96.44M	75.72M	80.15M	89.39M	101.45M	86.66M	77.91M	42.05M	51M	58.43M	49.54M	9.79M	-16.9M	31.4M	33.64M	38.44M
EBIT	23.91M	39.92M	33.97M	44.68M	53.96M	65.99M	49.55M	39.66M	3.87M	12.78M	20.48M	11.12M	-10.01M	-34.12M	14.15M	16.41M	21.2M
Depreciation & Amortization	56.56M	56.51M	41.75M	35.47M	35.43M	35.46M	37.11M	38.25M	38.18M	38.22M	37.95M	38.43M	19.8M	17.22M	17.25M	17.23M	17.24M